MedPath

Effectiveness of ozone gel placed in gums of patients with gum disease.

Phase 3
Not yet recruiting
Conditions
Chronic periodontitis
Chronic periodontitis,
Registration Number
CTRI/2025/05/086087
Lead Sponsor
TPCTs Terna Dental College
Brief Summary

This is a randomized clinical split mouth study to evaluatethe clinical efficacy of sub-gingivally delivered ozone as an adjunct to scalingand root plaing in patients undergoing non-surgical treatment of chronicperiodontitis. It is a split-mouth study.

Study design :

Group 1 consisting of 15 sites with 4-7mm pockets, receivingozone as a local drug delivery agent along with scaling and root planning.

Group 2 consisting of 15 sites with 4-7mm pockets, receivingundergoing scaling and root planning alone.

The clinical parameters [ plaque index, gingival index,relative attachment loss, probing pocket depth , modified sulcular bleedingindex]will be evaluated at baseline, one month and three month period.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

1)Adult patients 2)Bilateral periodontal sites, presence of at least one site in each quadrant with a probing depth of 5-7mm 3)Absence of systemic disease.

Exclusion Criteria
  1. Absence of dental implants 2) Use of bisphosphonates 12 months prior to entry in the study 3) Pregnant/ lactating women 4) Anti-cancer therapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the efficacy of Ozone Gel as an adjunct to scaling and root planing versus scaling and root planing alone for Non-surgical treatment of Chronic Periodontitis.At baseline | After 1 month | After 3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Terna Dental College

🇮🇳

Thane, MAHARASHTRA, India

Terna Dental College
🇮🇳Thane, MAHARASHTRA, India
Dr Sanika Patil
Principal investigator
7420830981
drsanika99@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.